"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Descriptor ID |
D001932
|
| MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
| Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 9 | 2 | 11 |
| 1997 | 9 | 2 | 11 |
| 1998 | 3 | 4 | 7 |
| 1999 | 11 | 4 | 15 |
| 2000 | 11 | 0 | 11 |
| 2001 | 12 | 1 | 13 |
| 2002 | 6 | 2 | 8 |
| 2003 | 15 | 3 | 18 |
| 2004 | 7 | 0 | 7 |
| 2005 | 15 | 1 | 16 |
| 2006 | 21 | 2 | 23 |
| 2007 | 17 | 2 | 19 |
| 2008 | 11 | 1 | 12 |
| 2009 | 22 | 2 | 24 |
| 2010 | 28 | 1 | 29 |
| 2011 | 27 | 3 | 30 |
| 2012 | 15 | 3 | 18 |
| 2013 | 31 | 1 | 32 |
| 2014 | 27 | 3 | 30 |
| 2015 | 27 | 0 | 27 |
| 2016 | 24 | 1 | 25 |
| 2017 | 19 | 2 | 21 |
| 2018 | 20 | 4 | 24 |
| 2019 | 21 | 2 | 23 |
| 2020 | 18 | 1 | 19 |
| 2021 | 25 | 1 | 26 |
| 2022 | 16 | 0 | 16 |
| 2023 | 28 | 2 | 30 |
| 2024 | 8 | 4 | 12 |
| 2025 | 21 | 2 | 23 |
| 2026 | 19 | 0 | 19 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. Br J Radiol. 2026 Oct 01; 99(1186):2148-2154.
-
High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
Beam geometry optimization and convergence mode evaluation for knowledge-based planning of hippocampal avoidance whole-brain radiotherapy: A cross-platform study with quantitative scorecard assessment. J Appl Clin Med Phys. 2026 Sep; 27(9):e70771.
-
Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells. Nat Cancer. 2026 Sep; 7(9):1387-1405.
-
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205. Clin Cancer Res. 2026 Aug 14; 32(16):3476-3492.
-
Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis. J Neurooncol. 2026 Jul 15; 178(3).
-
Tumor-targeted interferon-a gene therapy for glioblastoma: a phase 1 trial. Nat Med. 2026 Jun; 32(6):2216-2226.
-
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data. J Clin Oncol. 2026 Jul 20; 44(21):2048-2058.
-
Gene regulatory network analysis identifies dysregulation of hypoxia pathways as contributing to glioblastoma treatment resistance in females. Biol Sex Differ. 2026 05 21; 17(1).
-
Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors. J Neurooncol. 2026 May 07; 177(3).